These glycan differences overall were most starkly observed in HF-MUC2 O-glycans from the active CD patient samples, which showed greater overall relative abundance of glycan chains modified by sialic acid alone or with both sialic acid and fucose (Fig. 6C). The gene discussed is MUC2; the disease is hydrops fetalis.